Advances in Diagnosis and Management of Cutaneous Adverse Drug Reactions: Current and Future Trends,Used

Advances in Diagnosis and Management of Cutaneous Adverse Drug Reactions: Current and Future Trends,Used

In Stock
SKU: SONG9811314888
Brand: Springer
$57.68
Quantity
Add to wishlist
Add to compare

Processing time: 1-3 days

US Orders Ships in: 3-5 days

International Orders Ships in: 8-12 days

Return Policy: 15-days return on defective items

Payment Option
Payment Methods

Help

If you have any questions, you are always welcome to contact us. We'll get back to you as soon as possible, withing 24 hours on weekdays.

Customer service

All questions about your order, return and delivery must be sent to our customer service team by e-mail at yourstore@yourdomain.com

Sale & Press

If you are interested in selling our products, need more information about our brand or wish to make a collaboration, please contact us at press@yourdomain.com

This resource guides prescribers, pharmacists, and regulators with an update on the recent expansion of basic and clinical knowledge that forms a framework for understanding cutaneous reactions. This understanding will lead, in turn, to better outcomes and decisions in treatment and management, both in the clinic and in the life cycle of drug development.The skin is a common target for adverse drug events and even mild rashes can be part of lifethreatening syndromes. Patients and practitioners often face important decisions about therapy after a drug eruption, including treatment, crossreactivity with future pharmaceuticals, genetic considerations and dealing with longterm sequelae after a reaction. An international team of experts and leaders in the field share their story and insights into the scientific details and relevant clinical context.

⚠️ WARNING (California Proposition 65):

This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.

For more information, please visit www.P65Warnings.ca.gov.

Recently Viewed